1. Home
  2. EDSA vs ABTS Comparison

EDSA vs ABTS Comparison

Compare EDSA & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • ABTS
  • Stock Information
  • Founded
  • EDSA 2015
  • ABTS 2010
  • Country
  • EDSA Canada
  • ABTS Hong Kong
  • Employees
  • EDSA N/A
  • ABTS N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • ABTS Computer Software: Programming Data Processing
  • Sector
  • EDSA Health Care
  • ABTS Technology
  • Exchange
  • EDSA Nasdaq
  • ABTS Nasdaq
  • Market Cap
  • EDSA 13.8M
  • ABTS 9.8M
  • IPO Year
  • EDSA N/A
  • ABTS N/A
  • Fundamental
  • Price
  • EDSA $2.04
  • ABTS $5.09
  • Analyst Decision
  • EDSA Strong Buy
  • ABTS
  • Analyst Count
  • EDSA 2
  • ABTS 0
  • Target Price
  • EDSA $13.00
  • ABTS N/A
  • AVG Volume (30 Days)
  • EDSA 14.6K
  • ABTS 50.8K
  • Earning Date
  • EDSA 08-08-2025
  • ABTS 08-16-2025
  • Dividend Yield
  • EDSA N/A
  • ABTS N/A
  • EPS Growth
  • EDSA N/A
  • ABTS N/A
  • EPS
  • EDSA N/A
  • ABTS N/A
  • Revenue
  • EDSA N/A
  • ABTS $6,711,225.00
  • Revenue This Year
  • EDSA N/A
  • ABTS N/A
  • Revenue Next Year
  • EDSA N/A
  • ABTS N/A
  • P/E Ratio
  • EDSA N/A
  • ABTS N/A
  • Revenue Growth
  • EDSA N/A
  • ABTS 299.11
  • 52 Week Low
  • EDSA $1.55
  • ABTS $1.35
  • 52 Week High
  • EDSA $5.59
  • ABTS $14.10
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 52.18
  • ABTS 64.83
  • Support Level
  • EDSA $1.99
  • ABTS $3.53
  • Resistance Level
  • EDSA $2.14
  • ABTS $4.28
  • Average True Range (ATR)
  • EDSA 0.12
  • ABTS 0.53
  • MACD
  • EDSA 0.02
  • ABTS 0.03
  • Stochastic Oscillator
  • EDSA 58.62
  • ABTS 87.12

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.

Share on Social Networks: